S

Shandong Boan Biotechnology Co Ltd
HKEX:6955

Watchlist Manager
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Watchlist
Price: 8.86 HKD 0.91% Market Closed
Market Cap: 4.7B HKD
Have any thoughts about
Shandong Boan Biotechnology Co Ltd?
Write Note

Shandong Boan Biotechnology Co Ltd
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shandong Boan Biotechnology Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Boan Biotechnology Co Ltd
HKEX:6955
EPS (Diluted)
ÂĄ0
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
EPS (Diluted)
-ÂĄ4
CAGR 3-Years
17%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
EPS (Diluted)
ÂĄ0
CAGR 3-Years
6%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
EPS (Diluted)
ÂĄ0
CAGR 3-Years
-5%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
EPS (Diluted)
ÂĄ1
CAGR 3-Years
-36%
CAGR 5-Years
3%
CAGR 10-Years
34%
Imeik Technology Development Co Ltd
SZSE:300896
EPS (Diluted)
ÂĄ6
CAGR 3-Years
35%
CAGR 5-Years
52%
CAGR 10-Years
N/A
No Stocks Found

Shandong Boan Biotechnology Co Ltd
Glance View

Market Cap
4.5B HKD
Industry
Biotechnology

Shandong Boan Biotechnology Co., Ltd. operates as a biopharmaceutical company that specializes in therapeutic antibody development, manufacturing and commercialization. The company is headquartered in Yantai, Shandong and currently employs 631 full-time employees. The company went IPO on 2022-12-30. The firm is engaged in the development, production and commercialisation of therapeutic antibodies, focusing on the therapeutic areas of oncology, metabolism, autoimmunology and ophthalmology. The firm has three main technology platforms: a fully human antibody transgenic mouse and phage display technology platform, a bispecific T-cell Engager technology platform, and an antibody drug coupling (ADC) technology platform. The firm operates mainly in the domestic Chinese market and overseas markets.

Intrinsic Value
12.74 HKD
Undervaluation 30%
Intrinsic Value
Price
S

See Also

What is Shandong Boan Biotechnology Co Ltd's EPS (Diluted)?
EPS (Diluted)
-0.2 CNY

Based on the financial report for Dec 31, 2023, Shandong Boan Biotechnology Co Ltd's EPS (Diluted) amounts to -0.2 CNY.

What is Shandong Boan Biotechnology Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
21%

Over the last year, the EPS (Diluted) growth was 66%. The average annual EPS (Diluted) growth rates for Shandong Boan Biotechnology Co Ltd have been 21% over the past three years .

Back to Top